Update on 1 February 2019
The Department of Health and Social Care (DHSC) has told us that Carbagen (carbamazepine) tablets will be out of stock until mid to late 2019. This applies to both the immediate-release and prolonged-release tablets (previously called Carbagen SR).
The DHSC has written to doctors advising them to switch their patients from Carbagen to Tegretol. Tegretol is another brand of carbamazepine, and is available in both immediate-release and prolonged-release tablets. If you have any concerns about taking a different version of your medicine, speak to your GP, epilepsy nurse or epilepsy specialist.
Mylan has told us that both Carbagen (carbamazepine) and Carbagen SR (prolonged-release carbamazepine) are out of stock.
This is due to manufacturing issues. Mylan does not expect to return to normal stock levels until the middle of 2019. We will update this page as soon as we know more.
Other manufacturer’s versions of both standard and prolonged release carbamazepine are available. If you have any concerns about taking a different version of your medicine, speak to your GP, epilepsy nurse or epilepsy specialist.